Clin2
NCT07263191Possibly a fitRecruiting

Olanzapine study for bipolar disorder

Bipolar Disorder

Treatments studied

Part of Mental health clinical trials.

This study looks at how well patients with bipolar disorder do while taking the medication olanzapine. You will continue your regular treatment, and answer questions about your experience.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
19 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with bipolar disorder and are scheduled to receive the medication olanzapine.
  • You are able to understand the study questions and answer them on your own.
  • You are not pregnant, planning to become pregnant, or breastfeeding.
  • You have not taken an experimental drug or joined another clinical trial in the last 12 weeks.
  • The study doctor has not found any other reason that would make it unsafe or unsuitable for you to join.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06011460Enrolling by invitation
Observing clozapine safety for bipolar depression

This study is testing whether clozapine, a medication usually used for schizophrenia, is safe for treating hard-to-treat depression in people with bipolar disorder. It may help if you have not found relief from other treatments.

Gdansk, Pomeranian Voivodeship
NCT05891639Not yet recruiting
Study of patient experiences in bipolar disorder trials

This study looks at how people with bipolar disorder experience clinical trials and what helps or feels difficult. You may be eligible if you’re an adult with bipolar disorder and can complete regular electronic check-ins and consent forms.

San Francisco, California
NCT07172516Recruiting· Phase 3
Study of azetukalner vs placebo for bipolar depression

This trial tests whether the study drug azetukalner can help reduce depression symptoms in people with bipolar I or II disorder who are currently having a depressive episode. You would be randomly assigned to receive either the drug or a placebo (inactive pill) to see which works better.

Tucson, Arizona
NCT06821945Recruiting· Phase 2
Olanzapine dosing study for schizophrenia

This trial tests a slower, lower-dose schedule of the drug olanzapine for people with schizophrenia. It aims to see if a gentler start is safer and works as well, especially for those who may need less medication due to other health conditions.

Daegu
NCT06649214Not yet recruiting· Phase 3
Study of a new schizophrenia medication tablets

This trial tests a new combination tablet (olanzapine-samidorphan) for adults with schizophrenia. It aims to see if it helps control symptoms while potentially reducing weight gain, which can be a side effect of some schizophrenia medicines.

NCT06740890Recruiting· Phase 4
Exercise and a new medication for schizophrenia or bipolar disorder

This study tests whether a combination of a daily medication (olanzapine-samidorphan) and a structured exercise program can help people with schizophrenia, schizoaffective disorder, or bipolar disorder improve their health and well-being.

New York, New York

Hear when a new Bipolar Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.